Megan D. Jones
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Interests
Megan D. Jones has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Jordan M. Glenn
Neurotrack Technologies, Redwood City, CA USA
9 shared publications - Joshua L. Gills
NYU Grossman School of Medicine, New York, NY USA
9 shared publications - Michelle Gray
Exercise Science Research Center, University of Arkansas, Fayetteville, AR, United States
9 shared publications - Sally Paulson
St. Elizabeth Healthcare, Edgewood, KY, USA
9 shared publications - Anthony Campitelli
University of Arkansas at Fayetteville, Fayetteville, AR USA
8 shared publications - Erica Nicole Madero
Neurotrack Technologies, Inc, Redwood City, CA, United States
8 shared publications
Latest Publications
- Open Access
- 22 July 2024
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 8 (1) , e51400
Initial Perspectives From Rural-Residing Adults on a Digital Cognitive Health Coaching Intervention: Exploratory Qualitative Analysis
Background: A growing body of research has examined lifestyle-based interventions for dementia prevention. Specifically, health coaching interventions have been linked to decreased risk of Alzheimer disease (AD) comorbidities, such as diabetes. Despite the association, there is a lack of research examining the efficacy and perception of digital health coaching on reducing AD risk. Understanding the perceived benefits of participating in a digital health coach program is critical to ensure long-term use, including participant adherence and engagement. Objective: The purpose of this study is to examine the initial attitudes toward a digital health coaching intervention aimed at preventing cognitive decline among at-risk, rural participants. Methods: This exploratory qualitative study is part of the ongoing Digital Cognitive Multidomain Alzheimer Risk Velocity Study (DC-MARVel; ClinicalTrials.gov NCT04559789), a 2-year randomized control trial examining the effects of a digital health coaching intervention on dementia risk, cognitive decline, and general health outcomes. Participants were recruited from the northwest region of Arkansas via word of mouth, email, local radio, and social media. At the time of the analysis, 103 participants randomly assigned to the health coaching group completed an average of 4 coaching sessions over a 4-month period. The intervention included asynchronous messages 1-2 times per week from their health coach that contained health education articles based on the participant’s goals (eg, increase physical activity), unlimited access to their coach for questions and recommendations, and monthly meetings with their coach via videoconference or phone to discuss their goals. Participants were asked 2 open-ended questions, “What were your top 1 or 2 takeaways from your recent Health Coaching session?” and “Is there anything you would change about our Health Coaching sessions?” A thematic analysis was conducted using feedback responses from 80 participants (mean age, SD 7.6 years). Results: The following four themes emerged from participants’ feedback: (1) healthy lifestyle and behavioral changes, (2) a sense of self-awareness through introspection, (3) value in coach support, and (4) a desire for a change in program format (eg, frequency). In total, 93% (n=74) of participants expressed that the intervention needed no changes. Conclusions: Initial participation in the digital cognitive health coaching intervention was well received, as evidenced by participants reporting value in goal setting and strategies for healthy lifestyle and behavioral changes as well as self-reflection on their personal lifestyle choices. Feedback about their assigned coach also offers insight into the importance of the coach-participant relationship and may serve as a significant factor in overall participant success. Given the exploratory nature of this study, more robust research is needed to elicit more information from participants about their experiences to fully understand the acceptability of the digital health coaching intervention. Trial Registration: ClinicalTrials.gov NCT04559789; https://clinicaltrials.gov/show/NCT04559789 International Registered Report Identifier (IRRID): RR2-10.2196/31841
- 22 July 2024
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 8 (1) , e51400
Open AccessInitial Perspectives From Rural-Residing Adults on a Digital Cognitive Health Coaching Intervention: Exploratory Qualitative Analysis
Background: A growing body of research has examined lifestyle-based interventions for dementia prevention. Specifically, health coaching interventions have been linked to decreased risk of Alzheimer disease (AD) comorbidities, such as diabetes. Despite the association, there is a lack of research examining the efficacy and perception of digital health coaching on reducing AD risk. Understanding the perceived benefits of participating in a digital health coach program is critical to ensure long-term use, including participant adherence and engagement. Objective: The purpose of this study is to examine the initial attitudes toward a digital health coaching intervention aimed at preventing cognitive decline among at-risk, rural participants. Methods: This exploratory qualitative study is part of the ongoing Digital Cognitive Multidomain Alzheimer Risk Velocity Study (DC-MARVel; ClinicalTrials.gov NCT04559789), a 2-year randomized control trial examining the effects of a digital health coaching intervention on dementia risk, cognitive decline, and general health outcomes. Participants were recruited from the northwest region of Arkansas via word of mouth, email, local radio, and social media. At the time of the analysis, 103 participants randomly assigned to the health coaching group completed an average of 4 coaching sessions over a 4-month period. The intervention included asynchronous messages 1-2 times per week from their health coach that contained health education articles based on the participant’s goals (eg, increase physical activity), unlimited access to their coach for questions and recommendations, and monthly meetings with their coach via videoconference or phone to discuss their goals. Participants were asked 2 open-ended questions, “What were your top 1 or 2 takeaways from your recent Health Coaching session?” and “Is there anything you would change about our Health Coaching sessions?” A thematic analysis was conducted using feedback responses from 80 participants (mean age, SD 7.6 years). Results: The following four themes emerged from participants’ feedback: (1) healthy lifestyle and behavioral changes, (2) a sense of self-awareness through introspection, (3) value in coach support, and (4) a desire for a change in program format (eg, frequency). In total, 93% (n=74) of participants expressed that the intervention needed no changes. Conclusions: Initial participation in the digital cognitive health coaching intervention was well received, as evidenced by participants reporting value in goal setting and strategies for healthy lifestyle and behavioral changes as well as self-reflection on their personal lifestyle choices. Feedback about their assigned coach also offers insight into the importance of the coach-participant relationship and may serve as a significant factor in overall participant success. Given the exploratory nature of this study, more robust research is needed to elicit more information from participants about their experiences to fully understand the acceptability of the digital health coaching intervention. Trial Registration: ClinicalTrials.gov NCT04559789; https://clinicaltrials.gov/show/NCT04559789 International Registered Report Identifier (IRRID): RR2-10.2196/31841
- Open Access
- 25 December 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S15)
Physical function predicts declarative memory
Background: No cure currently exists for Alzheimer’s disease; however, early detection may help create therapies and treatments to slow cognitive decline. The concept of early detection is simple, but is complicated by the inability of primary care physicians to recognize symptoms until late disease manifestation and failure to provide appropriate screening tools for disease detection. Thus, the purpose of the present investigation was to determine predictors of cognitive performance among community‐dwelling older adults.Method: 63 community‐dwelling older adults (80.0 ± 5.5 years) participated in the present investigation. Declarative memory was used as the measure of cognition. Physical function was measured using the Short Physical Performance Battery (SPPB), dual‐task fast walking time, and sit‐to‐stand velocity. Linear regression analysis was used to predict cognition from physical function. Odds ratios were used to determine the magnitude of influence of physical function on cognitive function. ANOVA was used to determine differences in individual physical function variable between low and high cognitive groups.Results: The linear regression model included dual‐task fast 10‐m walking time, sex, education, and SPPB score and accounted for 39% of the variance in cognitive ability (p<.001). The physical function variables accounted for 8.8% and 8.5% of unique variance in cognition, respectively. For participants performing below the 50th percentile for dual‐task fast walking time, there was a 3.6‐fold increase in declarative memory scores (CI: 1.44‐9.35). Similarly, SPPB values indicative of mobility dysfunction was associated with a 3.2‐times increase in cognitive impairment (CI: 1.31‐7.87). Results of the one‐way ANOVA revealed significant differences in SPPB (p = .002), peak sit‐to‐stand velocity (p = .007), and dual‐task fast walking time (p = .001). The high cognitive group had significantly better physical function compared to the lower cognitive group.Conclusion: Results from the present investigation support the use of physical function in predicting current declarative memory among a sample of community‐dwelling adults with no diagnosed cognitive impairment. Future research is needed to determine the ability to predict changes in cognition longitudinally.
- 25 December 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S15)
Open AccessPhysical function predicts declarative memory
Background: No cure currently exists for Alzheimer’s disease; however, early detection may help create therapies and treatments to slow cognitive decline. The concept of early detection is simple, but is complicated by the inability of primary care physicians to recognize symptoms until late disease manifestation and failure to provide appropriate screening tools for disease detection. Thus, the purpose of the present investigation was to determine predictors of cognitive performance among community‐dwelling older adults.Method: 63 community‐dwelling older adults (80.0 ± 5.5 years) participated in the present investigation. Declarative memory was used as the measure of cognition. Physical function was measured using the Short Physical Performance Battery (SPPB), dual‐task fast walking time, and sit‐to‐stand velocity. Linear regression analysis was used to predict cognition from physical function. Odds ratios were used to determine the magnitude of influence of physical function on cognitive function. ANOVA was used to determine differences in individual physical function variable between low and high cognitive groups.Results: The linear regression model included dual‐task fast 10‐m walking time, sex, education, and SPPB score and accounted for 39% of the variance in cognitive ability (p<.001). The physical function variables accounted for 8.8% and 8.5% of unique variance in cognition, respectively. For participants performing below the 50th percentile for dual‐task fast walking time, there was a 3.6‐fold increase in declarative memory scores (CI: 1.44‐9.35). Similarly, SPPB values indicative of mobility dysfunction was associated with a 3.2‐times increase in cognitive impairment (CI: 1.31‐7.87). Results of the one‐way ANOVA revealed significant differences in SPPB (p = .002), peak sit‐to‐stand velocity (p = .007), and dual‐task fast walking time (p = .001). The high cognitive group had significantly better physical function compared to the lower cognitive group.Conclusion: Results from the present investigation support the use of physical function in predicting current declarative memory among a sample of community‐dwelling adults with no diagnosed cognitive impairment. Future research is needed to determine the ability to predict changes in cognition longitudinally.
- 1 December 2023
- Published by Human Kinetics in Journal of Aging and Physical Activity
- Vol. 31 (6) , 923-929
Differences in Habitual and Maximal Gait Velocity Across Age Groups: A Cross-Sectional Examination
Prior work, primarily focusing on habitual gait velocity, has demonstrated a cost while walking when coupled with a cognitive task. The cost of dual-task walking is exacerbated with age and complexity of the cognitive or motor task. However, few studies have examined the dual-task cost associated with maximal gait velocity. Thus, this cross-sectional study examined age-related changes in dual-task (serial subtraction) walking at two velocities. Participants were classified by age: young-old (45–64 years), middle-old (65–79 years), and oldest-old (≥80 years). They completed single- and dual-task walking trials for each velocity: habitual (N = 217) and maximal (N = 194). While no significant Group × Condition interactions existed for habitual or maximal gait velocities, the main effects for both condition and age groups were significant (p < .01). Maximal dual-task cost (p = .01) was significantly greater in the oldest-old group. With age, both dual-task velocities decreased. Maximal dual-task cost was greatest for the oldest-old group.
- 1 December 2023
- Published by Human Kinetics in Journal of Aging and Physical Activity
- Vol. 31 (6) , 923-929
Differences in Habitual and Maximal Gait Velocity Across Age Groups: A Cross-Sectional Examination
Prior work, primarily focusing on habitual gait velocity, has demonstrated a cost while walking when coupled with a cognitive task. The cost of dual-task walking is exacerbated with age and complexity of the cognitive or motor task. However, few studies have examined the dual-task cost associated with maximal gait velocity. Thus, this cross-sectional study examined age-related changes in dual-task (serial subtraction) walking at two velocities. Participants were classified by age: young-old (45–64 years), middle-old (65–79 years), and oldest-old (≥80 years). They completed single- and dual-task walking trials for each velocity: habitual (N = 217) and maximal (N = 194). While no significant Group × Condition interactions existed for habitual or maximal gait velocities, the main effects for both condition and age groups were significant (p < .01). Maximal dual-task cost (p = .01) was significantly greater in the oldest-old group. With age, both dual-task velocities decreased. Maximal dual-task cost was greatest for the oldest-old group.
- Open Access
- 1 August 2023
- Published by JMIR Publications Inc. in JMIR Preprints
Initial Perspectives From Rural-Residing Adults on a Digital Cognitive Health Coaching Intervention: Exploratory Qualitative Analysis (Preprint)
BACKGROUND A growing body of research has examined lifestyle-based interventions for dementia prevention. Specifically, health coaching interventions have been linked to decreased risk of Alzheimer disease (AD) comorbidities, such as diabetes. Despite the association, there is a lack of research examining the efficacy and perception of digital health coaching on reducing AD risk. Understanding the perceived benefits of participating in a digital health coach program is critical to ensure long-term use, including participant adherence and engagement. OBJECTIVE The purpose of this study is to examine the initial attitudes toward a digital health coaching intervention aimed at preventing cognitive decline among at-risk, rural participants. METHODS This exploratory qualitative study is part of the ongoing Digital Cognitive Multidomain Alzheimer Risk Velocity Study (DC-MARVel; ClinicalTrials.gov NCT04559789), a 2-year randomized control trial examining the effects of a digital health coaching intervention on dementia risk, cognitive decline, and general health outcomes. Participants were recruited from the northwest region of Arkansas via word of mouth, email, local radio, and social media. At the time of the analysis, 103 participants randomly assigned to the health coaching group completed an average of 4 coaching sessions over a 4-month period. The intervention included asynchronous messages 1-2 times per week from their health coach that contained health education articles based on the participant’s goals (eg, increase physical activity), unlimited access to their coach for questions and recommendations, and monthly meetings with their coach via videoconference or phone to discuss their goals. Participants were asked 2 open-ended questions, “What were your top 1 or 2 takeaways from your recent Health Coaching session?” and “Is there anything you would change about our Health Coaching sessions?” A thematic analysis was conducted using feedback responses from 80 participants (mean age, SD 7.6 years). RESULTS The following four themes emerged from participants’ feedback: (1) healthy lifestyle and behavioral changes, (2) a sense of self-awareness through introspection, (3) value in coach support, and (4) a desire for a change in program format (eg, frequency). In total, 93% (n=74) of participants expressed that the intervention needed no changes. CONCLUSIONS Initial participation in the digital cognitive health coaching intervention was well received, as evidenced by participants reporting value in goal setting and strategies for healthy lifestyle and behavioral changes as well as self-reflection on their personal lifestyle choices. Feedback about their assigned coach also offers insight into the importance of the coach-participant relationship and may serve as a significant factor in overall participant success. Given the exploratory nature of this study, more robust research is needed to elicit more information from participants about their experiences to fully understand the acceptability of the digital health coaching intervention. CLINICALTRIAL ClinicalTrials.gov NCT04559789; https://clinicaltrials.gov/show/NCT04559789 INTERNATIONAL REGISTERED REPORT RR2-10.2196/31841
- 1 August 2023
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessInitial Perspectives From Rural-Residing Adults on a Digital Cognitive Health Coaching Intervention: Exploratory Qualitative Analysis (Preprint)
BACKGROUND A growing body of research has examined lifestyle-based interventions for dementia prevention. Specifically, health coaching interventions have been linked to decreased risk of Alzheimer disease (AD) comorbidities, such as diabetes. Despite the association, there is a lack of research examining the efficacy and perception of digital health coaching on reducing AD risk. Understanding the perceived benefits of participating in a digital health coach program is critical to ensure long-term use, including participant adherence and engagement. OBJECTIVE The purpose of this study is to examine the initial attitudes toward a digital health coaching intervention aimed at preventing cognitive decline among at-risk, rural participants. METHODS This exploratory qualitative study is part of the ongoing Digital Cognitive Multidomain Alzheimer Risk Velocity Study (DC-MARVel; ClinicalTrials.gov NCT04559789), a 2-year randomized control trial examining the effects of a digital health coaching intervention on dementia risk, cognitive decline, and general health outcomes. Participants were recruited from the northwest region of Arkansas via word of mouth, email, local radio, and social media. At the time of the analysis, 103 participants randomly assigned to the health coaching group completed an average of 4 coaching sessions over a 4-month period. The intervention included asynchronous messages 1-2 times per week from their health coach that contained health education articles based on the participant’s goals (eg, increase physical activity), unlimited access to their coach for questions and recommendations, and monthly meetings with their coach via videoconference or phone to discuss their goals. Participants were asked 2 open-ended questions, “What were your top 1 or 2 takeaways from your recent Health Coaching session?” and “Is there anything you would change about our Health Coaching sessions?” A thematic analysis was conducted using feedback responses from 80 participants (mean age, SD 7.6 years). RESULTS The following four themes emerged from participants’ feedback: (1) healthy lifestyle and behavioral changes, (2) a sense of self-awareness through introspection, (3) value in coach support, and (4) a desire for a change in program format (eg, frequency). In total, 93% (n=74) of participants expressed that the intervention needed no changes. CONCLUSIONS Initial participation in the digital cognitive health coaching intervention was well received, as evidenced by participants reporting value in goal setting and strategies for healthy lifestyle and behavioral changes as well as self-reflection on their personal lifestyle choices. Feedback about their assigned coach also offers insight into the importance of the coach-participant relationship and may serve as a significant factor in overall participant success. Given the exploratory nature of this study, more robust research is needed to elicit more information from participants about their experiences to fully understand the acceptability of the digital health coaching intervention. CLINICALTRIAL ClinicalTrials.gov NCT04559789; https://clinicaltrials.gov/show/NCT04559789 INTERNATIONAL REGISTERED REPORT RR2-10.2196/31841
- Open Access
- 16 June 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S5)
High health coaching adherence increases Alzheimer’s protection in at‐risk inviduals following a 4‐month intervention
Background: Alzheimer’s disease and related dementias (ADRD) imposed an estimated financial cost to Americans of $355 billion in 2021 and is projected to rise to $1.1 trillion by 2050. ADRD affects more than 6 million Americans and is expected to rise to more than 13 million by 2050. Health coaching (HC) interventions improve many lifestyle factors also known to be protective against ADRD; however, their ability to provide protection in individuals at‐risk for developing cognitive decline is unknown. The purpose of the present investigation was to examine the effect of HC intervention adherence on ADRD protective factor score after 4 months.Method: Adults aged 45‐75 years (n = 104) with at least two ADRD risk factors and a maximum of one protective factor participated in this study. Participants completed the Australian National University Alzheimer’s Disease Risk Index (ANU‐ADRI) both before and after a 4‐month HC protocol focusing on reducing modifiable risk factors for ADRD in six domains (diet, exercise, sleep, stress, social engagement, and cognitive activity). Participants who completed a number of check‐ins with the health coach greater than the group mean (5.6 check‐ins) were placed in the high adherence (HA) group, and individuals with fewer were placed in the low adherence (LA) group. A mixed factorial ANOVA was conducted to determine if there was a difference in pre‐ and post‐ANU‐ADRI overall protective factor score.Result: After the 4‐month HC intervention, ANU‐ADRI scores did not change overall in the pooled sample (F(1,102) = 1.45, p = .23). However, a significant adherence*time interaction effect indicated that HA improved overall protective factor score significantly more than LA (F(1,102) = 4.85, p = .03), and pairwise comparisons revealed that protective factor scores improved only in the HA group (p = .02 for HA versus p = .47 for LA).Conclusion: These results indicate an HC intervention may effect behaviors and emotional states understood to be ADRD protective factors when adherence with the protocol is high. This has the potential to improve the quality of life for individuals at‐risk for ADRD. Further investigation will shed light on whether the ADRD protection derived from HC is iterative and durable.
- 16 June 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S5)
Open AccessHigh health coaching adherence increases Alzheimer’s protection in at‐risk inviduals following a 4‐month intervention
Background: Alzheimer’s disease and related dementias (ADRD) imposed an estimated financial cost to Americans of $355 billion in 2021 and is projected to rise to $1.1 trillion by 2050. ADRD affects more than 6 million Americans and is expected to rise to more than 13 million by 2050. Health coaching (HC) interventions improve many lifestyle factors also known to be protective against ADRD; however, their ability to provide protection in individuals at‐risk for developing cognitive decline is unknown. The purpose of the present investigation was to examine the effect of HC intervention adherence on ADRD protective factor score after 4 months.Method: Adults aged 45‐75 years (n = 104) with at least two ADRD risk factors and a maximum of one protective factor participated in this study. Participants completed the Australian National University Alzheimer’s Disease Risk Index (ANU‐ADRI) both before and after a 4‐month HC protocol focusing on reducing modifiable risk factors for ADRD in six domains (diet, exercise, sleep, stress, social engagement, and cognitive activity). Participants who completed a number of check‐ins with the health coach greater than the group mean (5.6 check‐ins) were placed in the high adherence (HA) group, and individuals with fewer were placed in the low adherence (LA) group. A mixed factorial ANOVA was conducted to determine if there was a difference in pre‐ and post‐ANU‐ADRI overall protective factor score.Result: After the 4‐month HC intervention, ANU‐ADRI scores did not change overall in the pooled sample (F(1,102) = 1.45, p = .23). However, a significant adherence*time interaction effect indicated that HA improved overall protective factor score significantly more than LA (F(1,102) = 4.85, p = .03), and pairwise comparisons revealed that protective factor scores improved only in the HA group (p = .02 for HA versus p = .47 for LA).Conclusion: These results indicate an HC intervention may effect behaviors and emotional states understood to be ADRD protective factors when adherence with the protocol is high. This has the potential to improve the quality of life for individuals at‐risk for ADRD. Further investigation will shed light on whether the ADRD protection derived from HC is iterative and durable.
- Open Access
- 27 January 2023
- Published by JMIR Publications Inc. in JMIR Aging
- Vol. 6 (1) , e36663
A Novel Digital Digit-Symbol Substitution Test Measuring Processing Speed in Adults At Risk for Alzheimer Disease: Validation Study
Background: Assessing cognitive constructs affected by Alzheimer disease, such as processing speed (PS), is important to screen for potential disease and allow for early detection. Digital PS assessments have been developed to provide widespread, efficient cognitive testing, but all have been validated only based on the correlation between test scores. Best statistical practices dictate that concurrent validity should be assessed for agreement or equivalence rather than using correlation alone. Objective: This study aimed to assess the concurrent validity of a novel digital PS assessment against a gold-standard measure of PS. Methods: Adults aged 45-75 years (n=191) participated in this study. Participants completed the novel digital digit-symbol substitution test (DDSST) and the Repeatable Battery for the Assessment of Neuropsychological Status coding test (RBANS-C). The correlation between the test scores was determined using a Pearson product-moment correlation, and a difference in mean test scores between tests was checked for using a 2-tailed dependent samples t test. Data were analyzed for agreement between the 2 tests using Bland-Altman limits of agreement and equivalency using a two one-sided t tests (TOST) approach. Results: A significant moderate, positive correlation was found between DDSST and RBANS-C scores (r=.577; P<.001), and no difference in mean scores was detected between the tests (P=.93). Bias was nearly zero (0.04). Scores between the tests were found to display adequate agreement with 90% of score differences falling between –22.66 and 22.75 (90% limits of agreement=–22.91 to 22.99), and the scores were equivalent (P=.049). Conclusions: Analyses indicate that the DDSST is a valid digital assessment of PS. The DDSST appears to be a suitable option for widespread, immediate, and efficient PS testing. Trial Registration: ClinicalTrials.gov NCT04559789; https://clinicaltrials.gov/ct2/show/NCT04559789
- 27 January 2023
- Published by JMIR Publications Inc. in JMIR Aging
- Vol. 6 (1) , e36663
Open AccessA Novel Digital Digit-Symbol Substitution Test Measuring Processing Speed in Adults At Risk for Alzheimer Disease: Validation Study
Background: Assessing cognitive constructs affected by Alzheimer disease, such as processing speed (PS), is important to screen for potential disease and allow for early detection. Digital PS assessments have been developed to provide widespread, efficient cognitive testing, but all have been validated only based on the correlation between test scores. Best statistical practices dictate that concurrent validity should be assessed for agreement or equivalence rather than using correlation alone. Objective: This study aimed to assess the concurrent validity of a novel digital PS assessment against a gold-standard measure of PS. Methods: Adults aged 45-75 years (n=191) participated in this study. Participants completed the novel digital digit-symbol substitution test (DDSST) and the Repeatable Battery for the Assessment of Neuropsychological Status coding test (RBANS-C). The correlation between the test scores was determined using a Pearson product-moment correlation, and a difference in mean test scores between tests was checked for using a 2-tailed dependent samples t test. Data were analyzed for agreement between the 2 tests using Bland-Altman limits of agreement and equivalency using a two one-sided t tests (TOST) approach. Results: A significant moderate, positive correlation was found between DDSST and RBANS-C scores (r=.577; P<.001), and no difference in mean scores was detected between the tests (P=.93). Bias was nearly zero (0.04). Scores between the tests were found to display adequate agreement with 90% of score differences falling between –22.66 and 22.75 (90% limits of agreement=–22.91 to 22.99), and the scores were equivalent (P=.049). Conclusions: Analyses indicate that the DDSST is a valid digital assessment of PS. The DDSST appears to be a suitable option for widespread, immediate, and efficient PS testing. Trial Registration: ClinicalTrials.gov NCT04559789; https://clinicaltrials.gov/ct2/show/NCT04559789
- Open Access
- 17 December 2022
- Published by Springer Nature in GeroScience
- Vol. 45 (2) , 1147-1159
The effect of a digital health coaching and health education protocol on cognition in adults at-risk for Alzheimer’s
Several modifiable lifestyle factors have been linked to cognitive ability and the risk of developing Alzheimer’s disease and related dementias (ADRD). Health coaching (HC) is an intervention that addresses lifestyle factors associated with cognition. The effectiveness of an HC protocol was evaluated and compared with a health education (HE) intervention, representing the current standard of care, in a sample of 216 adults between the ages of 45 and 75 years who were at-risk for developing ADRD. Outcomes examined were global cognition, neuropsychological cognition, and Alzheimer’s risk. HC participants received personalized coaching from a health coach focusing on nutrition, physical activity, sleep, stress, social engagement, and cognitive activity. HE participants received biweekly education materials focusing on the same modifiable lifestyle factors addressed by HC. Participants were assessed at baseline and again 4 months later. Self-reported global cognition scores improved only in the HC group (16.18 to 15.52, p = .03) and neuropsychological cognitive ability improved in the HE group (104.48 to 108.76, p < .001). When non-adherence in the HC group was accounted for, however, the mean change in neuropsychological score was similar between groups (p > .05), self-reported global cognition demonstrated an even larger mean improvement in the HC group (16.20 to 15.41, p = .01), and the HC group saw an improvement in ADRD protective risk score (− 10.39 to − 11.45, p = .007). These results indicate that HC and HE can both improve cognition, but HC may be more effective and may yield increased protection against ADRD risk.
- 17 December 2022
- Published by Springer Nature in GeroScience
- Vol. 45 (2) , 1147-1159
Open AccessThe effect of a digital health coaching and health education protocol on cognition in adults at-risk for Alzheimer’s
Several modifiable lifestyle factors have been linked to cognitive ability and the risk of developing Alzheimer’s disease and related dementias (ADRD). Health coaching (HC) is an intervention that addresses lifestyle factors associated with cognition. The effectiveness of an HC protocol was evaluated and compared with a health education (HE) intervention, representing the current standard of care, in a sample of 216 adults between the ages of 45 and 75 years who were at-risk for developing ADRD. Outcomes examined were global cognition, neuropsychological cognition, and Alzheimer’s risk. HC participants received personalized coaching from a health coach focusing on nutrition, physical activity, sleep, stress, social engagement, and cognitive activity. HE participants received biweekly education materials focusing on the same modifiable lifestyle factors addressed by HC. Participants were assessed at baseline and again 4 months later. Self-reported global cognition scores improved only in the HC group (16.18 to 15.52, p = .03) and neuropsychological cognitive ability improved in the HE group (104.48 to 108.76, p < .001). When non-adherence in the HC group was accounted for, however, the mean change in neuropsychological score was similar between groups (p > .05), self-reported global cognition demonstrated an even larger mean improvement in the HC group (16.20 to 15.41, p = .01), and the HC group saw an improvement in ADRD protective risk score (− 10.39 to − 11.45, p = .007). These results indicate that HC and HE can both improve cognition, but HC may be more effective and may yield increased protection against ADRD risk.
- Open Access
- 4 February 2022
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 11 (2) , e31841
Intervention for a Digital, Cognitive, Multi-Domain Alzheimer Risk Velocity Study: Protocol for a Randomized Controlled Trial
Background: In the United States, more than 6 million adults live with Alzheimer disease (AD) that affects 1 out of every 3 older adults. Although there is no cure for AD currently, lifestyle-based interventions aimed at slowing the rate of cognitive decline or delaying the onset of AD have shown promising results. However, most studies primarily focus on older adults (>55 years) and use in-person interventions. Objective: The aim of this study is to determine the effects of a 2-year digital lifestyle intervention on AD risk among at-risk middle-aged and older adults (45-75 years) compared with a health education control. Methods: The lifestyle intervention consists of a digitally delivered, personalized health coaching program that directly targets the modifiable risk factors for AD. The primary outcome measure is AD risk as determined by the Australian National University-Alzheimer Disease Risk Index; secondary outcome measures are functional fitness, blood biomarkers (inflammation, glucose, cholesterol, and triglycerides), and cognitive function (Repeatable Battery for the Assessment of Neuropsychological Status and Neurotrack Cognitive Battery). Screening commenced in January 2021 and was completed in June 2021. Results: Baseline characteristics indicate no difference between the intervention and control groups for AD risk (mean −1.68, SD 7.31; P=.90). Conclusions: The intervention in the Digital, Cognitive, Multi-domain Alzheimer Risk Velocity is uniquely designed to reduce the risk of AD through a web-based health coaching experience that addresses the modifiable lifestyle-based risk factors. Trial Registration: ClinicalTrials.gov NCT04559789; https://clinicaltrials.gov/show/NCT04559789 International Registered Report Identifier (IRRID): DERR1-10.2196/31841
- 4 February 2022
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 11 (2) , e31841
Open AccessIntervention for a Digital, Cognitive, Multi-Domain Alzheimer Risk Velocity Study: Protocol for a Randomized Controlled Trial
Background: In the United States, more than 6 million adults live with Alzheimer disease (AD) that affects 1 out of every 3 older adults. Although there is no cure for AD currently, lifestyle-based interventions aimed at slowing the rate of cognitive decline or delaying the onset of AD have shown promising results. However, most studies primarily focus on older adults (>55 years) and use in-person interventions. Objective: The aim of this study is to determine the effects of a 2-year digital lifestyle intervention on AD risk among at-risk middle-aged and older adults (45-75 years) compared with a health education control. Methods: The lifestyle intervention consists of a digitally delivered, personalized health coaching program that directly targets the modifiable risk factors for AD. The primary outcome measure is AD risk as determined by the Australian National University-Alzheimer Disease Risk Index; secondary outcome measures are functional fitness, blood biomarkers (inflammation, glucose, cholesterol, and triglycerides), and cognitive function (Repeatable Battery for the Assessment of Neuropsychological Status and Neurotrack Cognitive Battery). Screening commenced in January 2021 and was completed in June 2021. Results: Baseline characteristics indicate no difference between the intervention and control groups for AD risk (mean −1.68, SD 7.31; P=.90). Conclusions: The intervention in the Digital, Cognitive, Multi-domain Alzheimer Risk Velocity is uniquely designed to reduce the risk of AD through a web-based health coaching experience that addresses the modifiable lifestyle-based risk factors. Trial Registration: ClinicalTrials.gov NCT04559789; https://clinicaltrials.gov/show/NCT04559789 International Registered Report Identifier (IRRID): DERR1-10.2196/31841
- Open Access
- 6 July 2021
- Published by JMIR Publications Inc. in JMIR Preprints
Intervention for a Digital, Cognitive, Multi-Domain Alzheimer Risk Velocity Study: Protocol for a Randomized Controlled Trial (Preprint)
BACKGROUND In the United States, more than 6 million adults live with Alzheimer disease (AD) that affects 1 out of every 3 older adults. Although there is no cure for AD currently, lifestyle-based interventions aimed at slowing the rate of cognitive decline or delaying the onset of AD have shown promising results. However, most studies primarily focus on older adults (>55 years) and use in-person interventions. OBJECTIVE The aim of this study is to determine the effects of a 2-year digital lifestyle intervention on AD risk among at-risk middle-aged and older adults (45-75 years) compared with a health education control. METHODS The lifestyle intervention consists of a digitally delivered, personalized health coaching program that directly targets the modifiable risk factors for AD. The primary outcome measure is AD risk as determined by the Australian National University-Alzheimer Disease Risk Index; secondary outcome measures are functional fitness, blood biomarkers (inflammation, glucose, cholesterol, and triglycerides), and cognitive function (Repeatable Battery for the Assessment of Neuropsychological Status and Neurotrack Cognitive Battery). Screening commenced in January 2021 and was completed in June 2021. RESULTS Baseline characteristics indicate no difference between the intervention and control groups for AD risk (mean −1.68, SD 7.31; P=.90). CONCLUSIONS The intervention in the Digital, Cognitive, Multi-domain Alzheimer Risk Velocity is uniquely designed to reduce the risk of AD through a web-based health coaching experience that addresses the modifiable lifestyle-based risk factors. CLINICALTRIAL ClinicalTrials.gov NCT04559789; https://clinicaltrials.gov/show/NCT04559789 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/31841
- 6 July 2021
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessIntervention for a Digital, Cognitive, Multi-Domain Alzheimer Risk Velocity Study: Protocol for a Randomized Controlled Trial (Preprint)
BACKGROUND In the United States, more than 6 million adults live with Alzheimer disease (AD) that affects 1 out of every 3 older adults. Although there is no cure for AD currently, lifestyle-based interventions aimed at slowing the rate of cognitive decline or delaying the onset of AD have shown promising results. However, most studies primarily focus on older adults (>55 years) and use in-person interventions. OBJECTIVE The aim of this study is to determine the effects of a 2-year digital lifestyle intervention on AD risk among at-risk middle-aged and older adults (45-75 years) compared with a health education control. METHODS The lifestyle intervention consists of a digitally delivered, personalized health coaching program that directly targets the modifiable risk factors for AD. The primary outcome measure is AD risk as determined by the Australian National University-Alzheimer Disease Risk Index; secondary outcome measures are functional fitness, blood biomarkers (inflammation, glucose, cholesterol, and triglycerides), and cognitive function (Repeatable Battery for the Assessment of Neuropsychological Status and Neurotrack Cognitive Battery). Screening commenced in January 2021 and was completed in June 2021. RESULTS Baseline characteristics indicate no difference between the intervention and control groups for AD risk (mean −1.68, SD 7.31; P=.90). CONCLUSIONS The intervention in the Digital, Cognitive, Multi-domain Alzheimer Risk Velocity is uniquely designed to reduce the risk of AD through a web-based health coaching experience that addresses the modifiable lifestyle-based risk factors. CLINICALTRIAL ClinicalTrials.gov NCT04559789; https://clinicaltrials.gov/show/NCT04559789 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/31841